Document Detail


18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
MedLine Citation:
PMID:  23544184     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiac involvement portends a poor prognosis inpatients with sarcoidosis. However, due to the non specific clinical manifestations of the disease, patchy myocardial involvement, and the limited diagnostic yield of diagnostic tests, early diagnosis of cardiac sarcoidosis has been exceedingly difficult. As a result, there is no standardized approach for the early diagnosis of cardiac sarcoidosis. Imaging modalities that can both identify disease and predict response to therapy are paramount to improve management of cardiac sarcoidosis. 18F-FDG PET has many practical advantages in assessing disease activity and monitoring treatment response in patients with cardiac sarcoidosis. Accumulating data support the growing role of 18F-fluorodeoxyglucose (18F-FDG)PET in the diagnosis and risk stratification of patients with cardiac sarcoidosis.
Authors:
Hicham Skali; Allison R Schulman; Sharmila Dorbala
Related Documents :
11139964 - Factors determining long-term outcomes and survival in patients with coronary artery di...
3092624 - Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and...
10386674 - In-vivo myocardial substrate alteration during perfused ventricular fibrillation.
8256704 - Determinants of induction of ventricular tachycardia in nonsustained ventricular tachyc...
10663764 - Magnetic resonance imaging of athlete's heart: myocardial mass, left ventricular functi...
7866934 - Detection of silent ischemia adds to the prognostic value of coronary anatomy and left ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current cardiology reports     Volume:  15     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-29     Completed Date:  2013-07-23     Revised Date:  2013-10-24    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  352     Citation Subset:  IM    
Affiliation:
Department of Medicine, Cardiovascular Division, Boston, MA 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiomyopathies / physiopathology,  radionuclide imaging*
Fluorodeoxyglucose F18 / diagnostic use
Humans
Positron-Emission Tomography and Computed Tomography / methods
Practice Guidelines as Topic
Prognosis
Radiopharmaceuticals / diagnostic use
Sarcoidosis / physiopathology,  radionuclide imaging*
Grant Support
ID/Acronym/Agency:
5K23HL092299-03/HL/NHLBI NIH HHS; K23 HL092299/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study.
Next Document:  ED-based protocols speed care to sickle cell patients, reduce repeat ED visits, and discharge admitt...